Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group.
Reboux PA, Azaïs H, Canova CH, Bendifallah S, Ouldamer L, Raimond E, Hudry D, Coutant C, Graesslin O, Touboul C, Collinet P, Bricou A, Huchon C, Daraï E, Ballester M, Lévêque J, Lavoué V, Koskas M, Uzan C, Canlorbe G.
Reboux PA, et al. Among authors: azais h.
J Gynecol Oncol. 2019 Jul;30(4):e53. doi: 10.3802/jgo.2019.30.e53. Epub 2019 Feb 7.
J Gynecol Oncol. 2019.
PMID: 31074238
Free PMC article.